EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

mRNA: A promising platform for cancer immunotherapy

Byoungjae Kong, Yelee Kim, Eun Hye Kim, Jung Soo Suk, Yoosoo Yang

Advanced Drug Delivery Reviews · 2023-08 · 199 · 114993

DOI: 10.1016/j.addr.2023.114993 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2023-08. Verfasst von Byoungjae Kong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Department of Ophthalmology, Jo…. Hauptthemen laut MEDLINE: COVID-19, Neoplasms. Die Arbeit wurde bisher 69-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NINDS NIH HHS, Ministry of Science, ICT and Future Planning.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19NeoplasmsHumansRNA, MessengerPandemicsImmunotherapy

Substanzen

RNA, Messenger

Autor:innen und Institutionen

  • Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
  • Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea; Department of Life Sciences, Korea University, Seoul 02841, Republic of Korea.
  • Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA; D…
  • Biomedical Research Division, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea. Electronic address: ysyang@kist.re.kr.

Förderung

  • NIDDK NIH HHS
  • NINDS NIH HHS
  • Ministry of Science, ICT and Future Planning
  • Korea Institute of Science and Technology
  • National Research Foundation of Korea
  • National Institutes of Health

Zitieren

APA

Kong, B., Kim, Y., Kim, E. H., Suk, J. S., & Yang, Y. (2023). mRNA: A promising platform for cancer immunotherapy. Advanced Drug Delivery Reviews, 199, 114993. https://doi.org/10.1016/j.addr.2023.114993

Vancouver

Kong B, Kim Y, Kim EH, Suk JS, Yang Y. mRNA: A promising platform for cancer immunotherapy. Advanced Drug Delivery Reviews. 2023;199:114993. doi:10.1016/j.addr.2023.114993

BibTeX
@article{Kong2023,
  author = {Kong, Byoungjae and Kim, Yelee and Kim, Eun Hye and Suk, Jung Soo and Yang, Yoosoo},
  title = {mRNA: A promising platform for cancer immunotherapy},
  journal = {Advanced Drug Delivery Reviews},
  year = {2023},
  volume = {199},
  pages = {114993},
  doi = {10.1016/j.addr.2023.114993}
}
Kostenlos starten →